dr. natasha leighl explains the impact of egfr mutations on lung cancer treatment #egfr #biomarker
Published 2 months ago • 197 plays • Length 0:27Download video MP4
Download video MP3
Similar videos
-
4:25
how to understand egfr t790m mutations | dana-farber cancer institute
-
37:44
deciphering the data in egfr - mutant nsclc
-
14:23
treatment updates: egfr-mutant lung cancer | 2024 living with egfr-mutant lung cancer patient forum
-
6:02
q & a with egfr-mutant lung cancer experts | 2024 living with egfr-mutant lung cancer patient forum
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
6:56
first-line therapy in the patient with egfr-mutant lung cancer
-
3:01
going from stage iv lung cancer to clean scans
-
5:32
introduction to egfr inhibitors
-
30:23
egfr biomarker community: hope living with lung cancer
-
2:35
does targeted therapy mean i don't need chemotherapy?
-
17:41
case #3: patient with egfr exon 21 l858r alteration nsclc- 2024 case based panel discussions
-
24:42
mechanisms of lung tumorigenesis by mutant egfr
-
3:00
egfr-resistant disease in lung cancer
-
2:18
egfr-mutant lung cancer: a patient's journey
-
1:09
current and novel treatment approaches for first-line egfr-m nsclc
-
3:30
understanding mutations and targeted therapy in lung cancer
-
2:13
lung cancer: egfr therapy
-
2:00
choosing first line therapy in egfr mutations
-
1:37
dr. scagliotti discusses egfr mutations in nsclc
-
4:08
targeted therapies in lung cancer
-
57:37
emerging role of egfr-targeted therapy in resectable lung cancer
-
7:51
nsclc: egfr inhibition and resistance mechanisms